Panic Disorder Market with COVID-19 Impact Analysis, By Treatment, By Dosage Form, By Route of Administration, By Distribution Channel, By End-Use, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2022-2028

List of Tables

Reprt Highlight:

Panic Disorder Market size was valued at USD 18,804.3 Million in 2021, expanding at a CAGR of 9.2% from 2022 to 2028.

A panic disorder is characterized by sudden, recurrent symptoms of worry and dread. Anxiety and stress can lead to panic disorders. Everyone strives to be at the top of their game in this fast-paced environment. Even surviving in the market is challenging due to the fierce competition there. Growth and expansion are reduced to a distant fantasy. People thus experience stress, anxiety, and burden. Shortness of breath, sweating, shaking, nausea, heart palpitations, and numbness are all signs of panic disorders. Treatment options for panic disorders include therapy, medication, and psychological approaches. Although not life-threatening, panic episodes can still have a negative impact on one's quality of life.

Market Dynamics

The market for panic disorders is expanding in terms of value due to a variety of variables. The National Institute of Mental Health (NIMH) reports that as people get older, anxiety disorders become more common. Adults with anxiety disorders account for 22.3% of those between the ages of 18 and 29 and 22.7% of those between the ages of 30 and 44. Anxiety disorders are less common in adults 45 to 59 years old (20.6%). Anxiety affects only 9% of those 60 years and older, making it less prevalent among the elderly. Additionally, 2.7% of persons suffer from panic disorders, including 3.8% of women and 1.6% of males. An increase in panic disorder diagnoses, particularly as a result of rising mental health. According to estimates based on diagnostic interview data from the National Comorbidity Survey Adolescent Supplement (NCS-A), 2.3% of U.S. teenagers (aged 13 to 18) had a severe impairment and 2.3% had panic disorder.

The market is experiencing revenue growth as a result of an increase in pharmaceutical research and development efforts for the symptomatic and targeted treatment of panic disorder. Each type of panic disorder has a unique and specific gene variation that can be identified to develop effective and focused genetic therapy. The general public can be informed about the illness. Scientists and inventors might take advantage of this as an opportunity to develop a potent treatment for panic disorder sufferers to continue market revenue growth.

Regional Analysis:

North America is predicted to account for the greatest revenue share over the projection period due to the introduction of novel treatment options in this region. Furthermore, higher healthcare expenditures, as well as the availability of treatment options, would aid to accelerate revenue growth in the region's industry. Furthermore, increased disease awareness, together with these factors, is likely to fuel revenue growth in the panic disorder market in the region throughout the forecast period. On the other hand, with the high population growth in nations like China and India, the region of Asia Pacific is anticipated to experience significant revenue CAGR over the projection period. Furthermore, the presence of generic manufacturers and the expansion of healthcare facilities in the region are anticipated to fuel market revenue growth over the projection period.

Recent Development:

In March 2019, The Food and Drug Administration (U.S. FDA) approved Spravato (esketamine) nasal spray. This new introduction is indicated for the treatment of depression in patients who have tried other antidepressants but found them ineffective when combined with an oral antidepressant (treatment-resistant depression).

In April 2019, McMaster University and Purdue Pharma Canada collaborated to conduct a Phase IV clinical trial on Methylphenidate Hydrochloride Controlled Release Capsules in adults with and without anxiety disorders.

Key features of the study:

This proposed research study on the Panic Disorder market provides market size (US$ Million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the Panic Disorder market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Panic Disorder market

The impact of COVID-19 on the Panic Disorder market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Panic Disorder market post-COVID will also be covered.

To give the users of this report a comprehensive view of the Panic Disorder market, we have also included a competitive landscape and key innovator analysis for the Panic Disorder market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Panic Disorder market.

In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.

The global Panic Disorder market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PANIC DISORDER MARKET KEY PLAYERS

Bristol-Myers Squibb Company
Teva Pharmaceutical Industries Ltd.
Noven Pharmaceuticals, Inc.
Eli Lilly and Company
Sumitomo Pharma Co., Ltd.
Shionogi & Co., Ltd.
Baxter
GSK plc.
Pfizer Inc.
Recordati Rare Diseases
Boehringer Ingelheim International GmbH
Bausch Health Companies Inc.

GLOBAL PANIC DISORDER MARKET, BY TREATMENT

Medication
Beta blockers
Serotonin and norepinephrine reuptake inhibitors (SNRIs)
Benzodiazepines
Anti-epilepsy
Others

GLOBAL PANIC DISORDER MARKET, BY DOSAGE FORM

Tablets
Injections
Others

GLOBAL PANIC DISORDER MARKET, BY ROUTE OF ADMINISTRATION

Oral
Parenteral
Others

GLOBAL PANIC DISORDER MARKET, BY DISTRIBUTION CHANNEL

Online
Offline

GLOBAL PANIC DISORDER MARKET, BY END-USE

Hospital pharmacies
Retailer pharmacies
Online pharmacy stores

GLOBAL PANIC DISORDER MARKET, BY REGION

North America
- The U.S.
- Canada

Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe

Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC

Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM

The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA

Product Code: ANV1010

1. Panic Disorder Market Overview

1.1. Study Scope

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Panic Disorder Market Snippet by Treatment
- 2.1.2. Panic Disorder Market Snippet by Dosage Form
- 2.1.3. Panic Disorder Market Snippet by Route of Administration
- 2.1.4. Panic Disorder Market Snippet by Distribution Channel
- 2.1.5. Panic Disorder Market Snippet by End-Use
- 2.1.6. Panic Disorder Market Snippet by Country
- 2.1.7. Panic Disorder Market Snippet by Region
2.2. Competitive Insights

3. Panic Disorder Key Market Trends

3.1. Panic Disorder Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Panic Disorder Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Panic Disorder Market Opportunities
3.4. Panic Disorder Market Future Trends

4. Panic Disorder Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Panic Disorder Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Panic Disorder Market Landscape

6.1. Panic Disorder Market Share Analysis, 2021
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Panic Disorder Market - By Treatment

7.1. Overview
- 7.1.1. Segment Share Analysis, By Treatment, 2021 & 2028 (%)
- 7.1.2. Medication
- 7.1.3. Beta blockers
- 7.1.4. Serotonin and norepinephrine reuptake inhibitors (SNRIs)
- 7.1.5. Benzodiazepines
- 7.1.6. Anti-epilepsy
- 7.1.7. Others

8. Panic Disorder Market - By Dosage Form

8.1. Overview
- 8.1.1. Segment Share Analysis, By Dosage Form, 2021 & 2028 (%)
- 8.1.2. Tablets
- 8.1.3. Injections
- 8.1.4. Others

9. Panic Disorder Market - By Route of Administration

9.1. Overview
- 9.1.1. Segment Share Analysis, By Route of Administration, 2021 & 2028 (%)
- 9.1.2. Oral
- 9.1.3. Parenteral
- 9.1.4. Others

10. Panic Disorder Market - By Distribution Channel

10.1. Overview
- 10.1.1. Segment Share Analysis, By Distribution Channel, 2021 & 2028 (%)
- 10.1.2. Online
- 10.1.3. Offline

11. Panic Disorder Market - By End-Use

11.1. Overview
- 11.1.1. Segment Share Analysis, By End-Use, 2021 & 2028 (%)
- 11.1.2. Hospital pharmacies
- 11.1.3. Retailer pharmacies
- 11.1.4. Online pharmacy stores

12. Panic Disorder Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Panic Disorder Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Panic Disorder Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Panic Disorder Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Panic Disorder Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Panic Disorder Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Treatment, 2017 - 2028 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Mode of Administration, 2017 - 2028 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End-Use, 2017 - 2028 (US$ Million)

13. Key Vendor Analysis- Panic Disorder Industry

13.1. Competitive Dashboard
13.2. Company Profiles
- 13.2.1. Bristol-Myers Squibb Company
- 13.2.2. Teva Pharmaceutical Industries Ltd.
- 13.2.3. Noven Pharmaceuticals, Inc.
- 13.2.4. Eli Lilly and Company
- 13.2.5. Sumitomo Pharma Co., Ltd.
- 13.2.6. Shionogi & Co., Ltd.
- 13.2.7. Baxter
- 13.2.8. GSK plc.
- 13.2.9. Pfizer Inc.
- 13.2.10. Recordati Rare Diseases
- 13.2.11. Boehringer Ingelheim International GmbH
- 13.2.12. Bausch Health Companies Inc.

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us

Product Code: ANV1010

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Panic Disorder Market: Treatment Snapshot (2021)
TABLE Segment Dashboard; Definition and Scope, by Treatment
TABLE Global Panic Disorder Market, by Treatment 2017-2028 (USD Million)
TABLE Panic Disorder Market: Dosage Form Snapshot (2021)
TABLE Segment Dashboard; Definition and Scope, by Dosage Form
TABLE Global Panic Disorder Market, by Dosage Form 2017-2028 (USD Million)
TABLE Panic Disorder Market: Regional snapshot (2021)
TABLE Panic Disorder Market: Mode of Administration Snapshot (2021)
TABLE Segment Dashboard; Definition and Scope, by Mode of Administration
TABLE Global Panic Disorder Market, by Mode of Administration 2017-2028 (USD Million)
TABLE Panic Disorder Market: Distribution Channel Snapshot (2021)
TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
TABLE Global Panic Disorder Market, by Distribution Channel 2017-2028 (USD Million)
TABLE Panic Disorder Market: End-Use Snapshot (2021)
TABLE Segment Dashboard; Definition and Scope, by End-Use
TABLE Global Panic Disorder Market, by End-Use 2017-2028 (USD Million)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Panic Disorder Market, by Region 2017-2028 (USD Million)
TABLE North America Panic Disorder Market, by Country, 2017-2028 (USD Million)
TABLE North America Panic Disorder Market, by Treatment, 2017-2028 (USD Million)
TABLE North America Panic Disorder Market, by Dosage Form, 2017-2028 (USD Million)
TABLE North America Panic Disorder Market, by Mode of Administration, 2017-2028 (USD Million)
TABLE North America Panic Disorder Market, by Distribution Channel, 2017-2028 (USD Million)
TABLE North America Panic Disorder Market, by End-Use, 2017-2028 (USD Million)
TABLE Europe Panic Disorder Market, by Country, 2017-2028 (USD Million)
TABLE Europe Panic Disorder Market, by Treatment, 2017-2028 (USD Million)
TABLE Europe Panic Disorder Market, by Dosage Form, 2017-2028 (USD Million)
TABLE Europe Panic Disorder Market, by Mode of Administration, 2017-2028 (USD Million)
TABLE Europe Panic Disorder Market, by Distribution Channel, 2017-2028 (USD Million)
TABLE Europe Panic Disorder Market, by End-Use, 2017-2028 (USD Million)
TABLE Asia Pacific Panic Disorder Market, by Country, 2017-2028 (USD Million)
TABLE Asia Pacific Panic Disorder Market, by Treatment, 2017-2028 (USD Million)
TABLE Asia Pacific Panic Disorder Market, by Dosage Form, 2017-2028 (USD Million)
TABLE Asia Pacific Panic Disorder Market, by Mode of Administration, 2017-2028 (USD Million)
TABLE Asia Pacific Panic Disorder Market, by Distribution Channel, 2017-2028 (USD Million)
TABLE Asia Pacific Panic Disorder Market, by End-Use, 2017-2028 (USD Million)
TABLE Latin America Panic Disorder Market, by Country, 2017-2028 (USD Million)
TABLE Latin America Panic Disorder Market, by Treatment, 2017-2028 (USD Million)
TABLE Latin America Panic Disorder Market, by Dosage Form, 2017-2028 (USD Million)
TABLE Latin America Panic Disorder Market, by Mode of Administration, 2017-2028 (USD Million)
TABLE Latin America Panic Disorder Market, by Distribution channel, 2017-2028 (USD Million)
TABLE Latin America Panic Disorder Market, by End-Use, 2017-2028 (USD Million)
TABLE Middle East and Africa Panic Disorder Market, by Country, 2017-2028 (USD Million)
TABLE Middle East and Africa Panic Disorder Market, by Treatment, 2017-2028 (USD Million)
TABLE Middle East and Africa Panic Disorder Market, by Dosage Form, 2017-2028 (USD Million)
TABLE Middle East and Africa Panic Disorder Market, by Mode of Administration, 2017-2028 (USD Million)
TABLE Middle East and Africa Panic Disorder Market, by Distribution Channel, 2017-2028 (USD Million)
TABLE Middle East and Africa Panic Disorder Market, by End-Use, 2017-2028 (USD Million)

List of Figures

FIGURE Panic Disorder Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2021
FIGURE Treatment segment market share analysis, 2021 & 2028
FIGURE Treatment segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Dosage Form segment market share analysis, 2021 & 2028
FIGURE Dosage Form segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Mode of Administration segment market share analysis, 2021 & 2028
FIGURE Mode of Administration segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Distribution Channel segment market share analysis, 2021 & 2028
FIGURE Distribution Channel segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE End-Use segment market share analysis, 2021 & 2028
FIGURE End-Use segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Regional segment market share analysis, 2021 & 2028
FIGURE Regional segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE North America Panic Disorder Market share and leading players, 2021
FIGURE Europe Panic Disorder Market share and leading players, 2021
FIGURE Asia Pacific Panic Disorder Market share and leading players, 2021
FIGURE Latin America Panic Disorder Market share and leading players, 2021
FIGURE Middle East and Africa Panic Disorder Market share and leading players, 2021
FIGURE North America market share analysis by country, 2021
FIGURE U.S. Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Canada Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Europe Panic Disorder Market share analysis by country, 2021
FIGURE Germany Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Spain Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Italy Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE France Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE UK Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Russia Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Netherlands Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Sweden Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Poland Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Rest of the Europe Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Asia Pacific Panic Disorder Market share analysis by country, 2021
FIGURE India Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE China Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Japan Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE South Korea Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Australia Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Thailand Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Indonesia Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Phillipines Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Rest of APAC Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Latin America Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Latin America Panic Disorder Market share analysis by country, 2021
FIGURE Brazil Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Mexico Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Argentina Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Colombia Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Rest of LATAM Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Middle East and Africa Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Middle East and Africa Panic Disorder Market share analysis by country, 2021
FIGURE Saudi Arabia Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE United Arab Emirates Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Israel Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Turkey Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Algeria Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Egypt Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
FIGURE Rest of MEA Panic Disorder Market size, forecast and trend analysis, 2017 to 2028 (USD Million)

Panic Disorder Market with COVID-19 Impact Analysis, By Treatment, By Dosage Form, By Route of Administration, By Distribution Channel, By End-Use, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2022-2028

Description

Table of Contents

List of Tables

Reprt Highlight:

Market Dynamics

Regional Analysis:

Recent Development:

Key features of the study:

SCOPE OF THE REPORT

GLOBAL PANIC DISORDER MARKET KEY PLAYERS

GLOBAL PANIC DISORDER MARKET, BY TREATMENT

GLOBAL PANIC DISORDER MARKET, BY DOSAGE FORM

GLOBAL PANIC DISORDER MARKET, BY ROUTE OF ADMINISTRATION

GLOBAL PANIC DISORDER MARKET, BY DISTRIBUTION CHANNEL

GLOBAL PANIC DISORDER MARKET, BY END-USE

GLOBAL PANIC DISORDER MARKET, BY REGION

Table of Contents

1. Panic Disorder Market Overview

2. Executive Summary

3. Panic Disorder Key Market Trends

4. Panic Disorder Industry Study

5. Panic Disorder Market: COVID-19 Impact Analysis

6. Panic Disorder Market Landscape

7. Panic Disorder Market - By Treatment

8. Panic Disorder Market - By Dosage Form

9. Panic Disorder Market - By Route of Administration

10. Panic Disorder Market - By Distribution Channel

11. Panic Disorder Market - By End-Use

12. Panic Disorder Market- By Geography

13. Key Vendor Analysis- Panic Disorder Industry

14. 360 Degree Analyst View

15. Appendix

List of Tables

List of Figures